{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T20:50:55Z","timestamp":1785617455547,"version":"3.56.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T00:00:00Z","timestamp":1778284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T00:00:00Z","timestamp":1778284800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Microbiol"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s00203-026-04931-5","type":"journal-article","created":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T08:05:57Z","timestamp":1778313957000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Detection of drug resistance mutations and spoligotype mapping in Mycobacterium tuberculosis using deeplex sequencing, including novel and uncharacterized spoligotypes"],"prefix":"10.1007","volume":"208","author":[{"given":"Andrea Michel","family":"Tovar-Nieto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Rivas-Santiago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Valentin","family":"Trujillo-Paez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"N\u00fa\u00f1ez-Contreras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar E.","family":"Gonzalez-Mu\u00f1iz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irma E.","family":"Gonzalez-Curiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime E.","family":"Huerta-Elias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Sevilla-Fuentes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Ernesto","family":"L\u00f3pez-Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adri\u00e1n","family":"Rodr\u00edguez-Carlos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,9]]},"reference":[{"key":"4931_CR22","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.jgar.2025.01.013","volume":"41","author":"I Alvarez-Maya","year":"2025","unstructured":"Alvarez-Maya I et al (2025) Nationwide phylogenomic surveillance of Mycobacterium tuberculosis in Mexico reveals pathogenic and drug resistant signatures of the prevailing L4 sublineage. J Glob Antimicrob Resist 41:224\u2013232","journal-title":"J Glob Antimicrob Resist"},{"key":"4931_CR7","first-page":"p8295261","volume":"2019","author":"JM Bello-L\u00f3pez","year":"2019","unstructured":"Bello-L\u00f3pez JM et al (2019) Morbidity Trends and Risk of Tuberculosis: Mexico 2007\u20132017. Can Respir J 2019:p8295261","journal-title":"Can Respir J"},{"issue":"8","key":"4931_CR24","first-page":"399","volume":"39","author":"V Bocanegra-Garc\u00eda","year":"2021","unstructured":"Bocanegra-Garc\u00eda V et al (2021) RDRioMycobacterium tuberculosis strains associated with isoniazid resistance in Northern Mexico. Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica. (English Edition) 39(8):399\u2013402","journal-title":"(English Edition)"},{"issue":"8","key":"4931_CR8","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.eimc.2020.07.003","volume":"39","author":"V Bocanegra-Garc\u00eda","year":"2021","unstructured":"Bocanegra-Garc\u00eda V et al (2021) RD(Rio)Mycobacterium tuberculosis strains associated with isoniazid resistance in Northern Mexico. Enferm Infecc Microbiol Clin (Engl Ed) 39(8):399\u2013402","journal-title":"Enferm Infecc Microbiol Clin (Engl Ed)"},{"key":"4931_CR15","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.meegid.2018.12.030","volume":"72","author":"D Couvin","year":"2019","unstructured":"Couvin D et al (2019) Macro-geographical specificities of the prevailing tuberculosis epidemic as seen through SITVIT2, an updated version of the Mycobacterium tuberculosis genotyping database. Infect Genet Evol 72:31\u201343","journal-title":"Infect Genet Evol"},{"key":"4931_CR14","doi-asserted-by":"publisher","first-page":"fuaf017","DOI":"10.1093\/femsre\/fuaf017","volume":"49","author":"D Couvin","year":"2025","unstructured":"Couvin D et al (2025) Molecular typing of Mycobacterium tuberculosis: a review of current methods, databases, softwares, and analytical tools. FEMS Microbiol Rev 49:fuaf017","journal-title":"FEMS Microbiol Rev"},{"key":"4931_CR4","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.tube.2017.04.007","volume":"105","author":"D Couvin","year":"2017","unstructured":"Couvin D, Zozio T, Rastogi N (2017) SpolSimilaritySearch \u2013 A web tool to compare and search similarities between spoligotypes of Mycobacterium tuberculosis complex. Tuberculosis 105:49\u201352","journal-title":"Tuberculosis"},{"issue":"1","key":"4931_CR29","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12866-019-1479-6","volume":"19","author":"CC D\u00edaz Acosta","year":"2019","unstructured":"D\u00edaz Acosta CC et al (2019) Exploring the Latin American Mediterranean family and the RDRio lineage in Mycobacterium tuberculosis isolates from Paraguay, Argentina and Venezuela. BMC Microbiol 19(1):131","journal-title":"BMC Microbiol"},{"issue":"10","key":"4931_CR36","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1038\/ng.2747","volume":"45","author":"MR Farhat","year":"2013","unstructured":"Farhat MR et al (2013) Genomic analysis identifies targets of convergent positive selection in drug-resistant Mycobacterium tuberculosis. Nat Genet 45(10):1183\u20131189","journal-title":"Nat Genet"},{"issue":"12","key":"4931_CR25","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.3855\/jidc.18026","volume":"17","author":"A Flores-Ar\u00e9chiga","year":"2023","unstructured":"Flores-Ar\u00e9chiga A et al (2023) Molecular epidemiology and drug resistance of Mycobacterium tuberculosis in a tertiary care hospital in northeastern Mexico. J Infect Dev Ctries 17(12):1753\u20131760","journal-title":"J Infect Dev Ctries"},{"issue":"1","key":"4931_CR32","doi-asserted-by":"publisher","first-page":"63","DOI":"10.21149\/spm.v56i1.7324","volume":"56","author":"S Flores-Trevi\u00f1o","year":"2014","unstructured":"Flores-Trevi\u00f1o S, Mendoza-Olazar\u00e1n S, Garza-Gonz\u00e1lez E (2014) Drug resistance and molecular epidemiology of Mycobacterium tuberculosis in Mexico: a systematic review. Salud Publica Mex 56(1):63\u201377","journal-title":"Salud Publica Mex"},{"issue":"4","key":"4931_CR30","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.meegid.2011.08.027","volume":"12","author":"HM Gomes","year":"2012","unstructured":"Gomes HM et al (2012) Spoligotypes of Mycobacterium tuberculosis complex isolates from patients residents of 11 states of Brazil. Infect Genet Evol 12(4):649\u2013656","journal-title":"Infect Genet Evol"},{"issue":"5","key":"4931_CR20","doi-asserted-by":"publisher","first-page":"e0126271","DOI":"10.1371\/journal.pone.0126271","volume":"10","author":"L Grandjean","year":"2015","unstructured":"Grandjean L et al (2015) The Association between Mycobacterium Tuberculosis Genotype and Drug Resistance in Peru. PLoS ONE 10(5):e0126271","journal-title":"PLoS ONE"},{"issue":"5","key":"4931_CR31","doi-asserted-by":"publisher","first-page":"e0126271","DOI":"10.1371\/journal.pone.0126271","volume":"10","author":"L Grandjean","year":"2015","unstructured":"Grandjean L et al (2015) The Association between Mycobacterium Tuberculosis Genotype and Drug Resistance in Peru. PLoS ONE 10(5):e0126271","journal-title":"PLoS ONE"},{"issue":"2","key":"4931_CR10","doi-asserted-by":"publisher","first-page":"e84","DOI":"10.1016\/S2666-5247(22)00301-9","volume":"4","author":"MB Hall","year":"2023","unstructured":"Hall MB et al (2023) Evaluation of Nanopore sequencing for Mycobacterium tuberculosis drug susceptibility testing and outbreak investigation: a genomic analysis. Lancet Microbe 4(2):e84\u2013e92","journal-title":"Lancet Microbe"},{"issue":"3","key":"4931_CR13","doi-asserted-by":"publisher","first-page":"2002338","DOI":"10.1183\/13993003.02338-2020","volume":"57","author":"A Jouet","year":"2021","unstructured":"Jouet A et al (2021) Deep amplicon sequencing for culture-free prediction of susceptibility or resistance to 13 anti-tuberculous drugs. Eur Respir J 57(3):2002338","journal-title":"Eur Respir J"},{"key":"4931_CR19","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.jgar.2022.06.013","volume":"30","author":"P Krittanan","year":"2022","unstructured":"Krittanan P et al (2022) Spoligotype-based population structure and isoniazid-resistance gene mutation of Mycobacterium tuberculosis isolates from Thailand. J Global Antimicrob Resist 30:319\u2013325","journal-title":"J Global Antimicrob Resist"},{"issue":"9","key":"4931_CR12","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.3390\/microorganisms13092163","volume":"13","author":"S Laatri","year":"2025","unstructured":"Laatri S et al (2025) Characterization of drug resistance mutations in Mycobacterium tuberculosis isolates from moroccan patients using deeplex targeted next-generation sequencing. Microorganisms 13(9):2163","journal-title":"Microorganisms"},{"issue":"5","key":"4931_CR3","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1183\/13993003.00629-2016","volume":"48","author":"Z Lan","year":"2016","unstructured":"Lan Z, Bastos M, Menzies D (2016) Treatment of human disease due to Mycobacterium bovis: a systematic review. Eur Respir J 48(5):1500\u20131503","journal-title":"Eur Respir J"},{"key":"4931_CR28","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/1756-0500-6-172","volume":"6","author":"E L\u00f3pez-Rocha","year":"2013","unstructured":"L\u00f3pez-Rocha E et al (2013) Genetic diversity of the Mycobacterium tuberculosis complex in San Luis Potos\u00ed, M\u00e9xico. BMC Res Notes 6:172","journal-title":"BMC Res Notes"},{"issue":"8","key":"4931_CR33","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.arcmed.2008.08.006","volume":"39","author":"A Martinez-Gamboa","year":"2008","unstructured":"Martinez-Gamboa A et al (2008) Molecular analysis of Mycobacterium tuberculosis strains with an intact pks15\/1 gene in a rural community of Mexico. Arch Med Res 39(8):809\u2013814","journal-title":"Arch Med Res"},{"key":"4931_CR34","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.meegid.2012.12.024","volume":"14","author":"A Martinez-Guarneros","year":"2013","unstructured":"Martinez-Guarneros A et al (2013) Genetic diversity among multidrug-resistant Mycobacterium tuberculosis strains in Mexico. Infect Genet Evol 14:434\u2013443","journal-title":"Infect Genet Evol"},{"key":"4931_CR17","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.ebiom.2018.10.013","volume":"37","author":"CJ Meehan","year":"2018","unstructured":"Meehan CJ et al (2018) The relationship between transmission time and clustering methods in Mycobacterium tuberculosis epidemiology. EBioMedicine 37:410\u2013416","journal-title":"EBioMedicine"},{"issue":"9","key":"4931_CR35","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/s41579-019-0214-5","volume":"17","author":"CJ Meehan","year":"2019","unstructured":"Meehan CJ et al (2019) Whole genome sequencing of Mycobacterium tuberculosis: current standards and open issues. Nat Rev Microbiol 17(9):533\u2013545","journal-title":"Nat Rev Microbiol"},{"issue":"10","key":"4931_CR23","doi-asserted-by":"publisher","first-page":"e0292965","DOI":"10.1371\/journal.pone.0292965","volume":"18","author":"PM Mej\u00eda-Ponce","year":"2023","unstructured":"Mej\u00eda-Ponce PM et al (2023) Genomic epidemiology analysis of drug-resistant Mycobacterium tuberculosis distributed in Mexico. PLoS ONE 18(10):e0292965","journal-title":"PLoS ONE"},{"issue":"3","key":"4931_CR37","doi-asserted-by":"publisher","first-page":"e0193626","DOI":"10.1371\/journal.pone.0193626","volume":"13","author":"D Munro-Rojas","year":"2018","unstructured":"Munro-Rojas D et al (2018) Genetic diversity of drug and multidrug-resistant Mycobacterium tuberculosis circulating in Veracruz, Mexico. PLoS ONE 13(3):e0193626","journal-title":"PLoS ONE"},{"issue":"14","key":"4931_CR5","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/S1286-4579(99)00243-9","volume":"1","author":"MN Niang","year":"1999","unstructured":"Niang MN et al (1999) Characterization of M. tuberculosis strains from West African patients by spoligotyping. Microbes Infect 1(14):1189\u20131192","journal-title":"Microbes Infect"},{"key":"4931_CR39","doi-asserted-by":"publisher","first-page":"104994","DOI":"10.1016\/j.meegid.2021.104994","volume":"93","author":"A Ordaz-V\u00e1zquez","year":"2021","unstructured":"Ordaz-V\u00e1zquez A et al (2021) Genetic diversity and primary drug resistance transmission in Mycobacterium tuberculosis in southern Mexico. Infect Genet Evol 93:104994","journal-title":"Infect Genet Evol"},{"key":"4931_CR6","first-page":"1586938","volume":"15","author":"D Qiu","year":"2025","unstructured":"Qiu D et al (2025) Prevalence and molecular characterization of drug-resistant Mycobacterium tuberculosis in Heyuan City in China. Microbiology 15:1586938","journal-title":"Microbiology"},{"issue":"8","key":"4931_CR27","doi-asserted-by":"publisher","first-page":"2716","DOI":"10.1128\/JCM.40.8.2716-2724.2002","volume":"40","author":"TN Quitugua","year":"2002","unstructured":"Quitugua TN et al (2002) Transmission of drug-resistant tuberculosis in Texas and Mexico. J Clin Microbiol 40(8):2716\u20132724","journal-title":"J Clin Microbiol"},{"issue":"1","key":"4931_CR40","doi-asserted-by":"publisher","first-page":"6780","DOI":"10.1038\/s41598-022-10488-2","volume":"12","author":"JP Smith","year":"2022","unstructured":"Smith JP et al (2022) Characterizing tuberculosis transmission dynamics in high-burden urban and rural settings. Sci Rep 12(1):6780","journal-title":"Sci Rep"},{"issue":"5","key":"4931_CR18","doi-asserted-by":"publisher","first-page":"e358","DOI":"10.1016\/S2666-5247(23)00002-2","volume":"4","author":"L Sonnenkalb","year":"2023","unstructured":"Sonnenkalb L et al (2023) Bedaquiline and clofazimine resistance in Mycobacterium tuberculosis: an in-vitro and in-silico data analysis. Lancet Microbe 4(5):e358\u2013e368","journal-title":"Lancet Microbe"},{"issue":"5","key":"4931_CR21","doi-asserted-by":"publisher","first-page":"428","DOI":"10.3390\/pathogens13050428","volume":"13","author":"D Valencia-Trujillo","year":"2024","unstructured":"Valencia-Trujillo D et al (2024) Genetic Diversity of Mycobacterium tuberculosis Strains Isolated from HIV-Infected Patients in Mexico. Pathogens 13(5):428","journal-title":"Pathogens"},{"issue":"8","key":"4931_CR26","doi-asserted-by":"publisher","first-page":"3049","DOI":"10.1128\/JCM.01043-14","volume":"52","author":"L Vera-Cabrera","year":"2014","unstructured":"Vera-Cabrera L et al (2014) Comparative Mycobacterium tuberculosis Spoligotype Distribution in Mexico. J Clin Microbiol 52(8):3049\u20133052","journal-title":"J Clin Microbiol"},{"key":"4931_CR41","volume-title":"The use of next-generation sequencing technologies for the detection of mutations associated with drug resistance in Mycobacterium tuberculosis complex: technical guide","author":"WHO","year":"2018","unstructured":"WHO (2018) The use of next-generation sequencing technologies for the detection of mutations associated with drug resistance in Mycobacterium tuberculosis complex: technical guide. WHO, Geneva"},{"key":"4931_CR16","volume-title":"Catalogue of mutations in Mycobacterium tuberculosis complex and their association with drug resistance","author":"WHO","year":"2023","unstructured":"WHO (2023) Catalogue of mutations in Mycobacterium tuberculosis complex and their association with drug resistance, 2nd edn. World Health Organization, Geneva","edition":"2"},{"key":"4931_CR1","volume-title":"Global tuberculosis report 2025","author":"WHO","year":"2025","unstructured":"WHO (2025) Global tuberculosis report 2025. WHO, Geneva"},{"key":"4931_CR2","volume-title":"The end TB strategy","author":"World Health Organization","year":"2015","unstructured":"World Health Organization (2015) The end TB strategy. WHO, Geneva"},{"key":"4931_CR9","doi-asserted-by":"publisher","DOI":"10.54394\/CJQU6666","volume-title":"Global Tuberculosis Report 2024","author":"World Health Organization","year":"2024","unstructured":"World Health Organization (2024) Global Tuberculosis Report 2024. WHO, Geneva"},{"key":"4931_CR11","doi-asserted-by":"publisher","DOI":"10.2471\/B09458","volume-title":"WHO consolidated guidelines on tuberculosis: module 4: treatment and care","author":"World Health Organization","year":"2025","unstructured":"World Health Organization (2025) WHO consolidated guidelines on tuberculosis: module 4: treatment and care. WHO, Geneva"},{"issue":"1","key":"4931_CR38","doi-asserted-by":"publisher","first-page":"7098","DOI":"10.1038\/s41598-025-90579-y","volume":"15","author":"JL Zacar\u00edas-Hern\u00e1ndez","year":"2025","unstructured":"Zacar\u00edas-Hern\u00e1ndez JL et al (2025) Geographical location and genotyping analysis of pulmonary tuberculosis in the state of Nuevo Leon, Mexico. Sci Rep 15(1):7098","journal-title":"Sci Rep"}],"container-title":["Archives of Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-026-04931-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00203-026-04931-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-026-04931-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T20:01:52Z","timestamp":1785614512000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00203-026-04931-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,9]]},"references-count":41,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["4931"],"URL":"https:\/\/doi.org\/10.1007\/s00203-026-04931-5","relation":{},"ISSN":["0302-8933","1432-072X"],"issn-type":[{"value":"0302-8933","type":"print"},{"value":"1432-072X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,9]]},"assertion":[{"value":"24 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no conflicts of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The present study was conducted in accordance with the principles of the Declaration of Helsinki, and the research protocol was approved by the National Scientific Research Committee of the Mexican Institute of Social Security (IMSS; R-2022-785-049). A total of 143 MTBC strains were obtained from the Biomedical Research Unit in Zacatecas-IMSS between 2024 and 2025 through the National Tuberculosis Surveillance Program in Mexico, in compliance with NOM-006-SSA2-2013 for the prevention and control of tuberculosis.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"380"}}